Heteroduplex formation in SMN gene dosage analysis. Academic Article uri icon

Overview

abstract

  • Most spinal muscular atrophy patients lack both copies of SMN1 exon 7 and most carriers have only one copy of SMN1 exon 7. We investigated the effect of SMN1/SMN2 heteroduplex formation on SMN gene dosage analysis, which is an assay to determine copy number of SMN1 exon 7 that utilizes multiplex quantitative polymerase chain reaction (PCR) with DraI digestion to differentiate SMN1 from SMN2. Heteroduplex formation in PCR is a well-described phenomenon. In addition to demonstrating the presence of heteroduplexes by sequence analysis of purified SMN1 bands, we compared the SMN1 signals in various genotype groups (total n = 260) to those in a group lacking SMN2 (n = 13), and we estimated the relative amounts of SMN1/SMN2 heteroduplexes. The SMN1 signal increased as SMN2 copy number increased despite a constant SMN1 copy number, although not all pairwise comparisons showed a statistically significant difference in the SMN1 signal. In conclusion, SMN1/SMN2 heteroduplexes form in SMN gene dosage analysis, falsely increasing the SMN1 signal. External controls for SMN gene dosage analysis should be chosen carefully with regard to SMN2 copy number. The effect of heteroduplex formation should be considered when performing quantitative multiplex PCR.

publication date

  • November 1, 2001

Research

keywords

  • Muscular Atrophy, Spinal
  • Nerve Tissue Proteins
  • Nucleic Acid Heteroduplexes

Identity

PubMed Central ID

  • PMC1906961

Scopus Document Identifier

  • 0035179032

Digital Object Identifier (DOI)

  • 10.1016/S1525-1578(10)60666-6

PubMed ID

  • 11687598

Additional Document Info

volume

  • 3

issue

  • 4